SUBSCRIBE
SUBSCRIBE
News   Business

Medgenics, Inc. Extends Collaboration with Baxter Healthcare Corporation on Development of Factor VIII Biopump

July 6, 2011 | 
1 min read
MISGAV, Israel and VIENNA, Va.--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) announces an extension of its agreement with Baxter Healthcare Corporation for the joint development of the Factor VIII Biopump.
Alliances Asia
MORE ON THIS TOPIC
Salary negotiation, pay raise discussion or wages and benefit agreement, business deal or merger and acquisition concept, business people handshake on pile of money banknote after finish agreement.
Obesity
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
August 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Time on the hourglass stopped. Clock on table. Pause in business, collapse.
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
August 24, 2026
 · 
1 min read
 · 
Tristan Manalac
The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.
Duchenne muscular dystrophy
Capricor investor calls for change as company awaits decision on Duchenne candidate
August 21, 2026
 · 
3 min read
 · 
Heather McKenzie
Businessmans hand holding a red globe with the map of China, symbolizing international business, trade, global markets, global influence, economics, or Chinese business ventures
Policy
Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths
August 21, 2026
 · 
4 min read
 · 
Gabrielle Masson